Drug recall · December 11, 2019
Fluphenazine Decanoate Injection USP 125mg/5mL recall
Why: Discoloration; Hazy solution found in one vial instead of a clear solution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ
- Lots / codes
Lot CFD190004, exp. date August 2020
- Quantity
- 59,500 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.
- Initiated
- November 12, 2019 · Voluntary: Firm initiated
- Classified
- December 9, 2019
- Reported
- December 11, 2019
- Ended
- January 21, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluphenazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.